BRISTOL MYERS SQUIBB
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 76
- Registration Number
- NCT05866627
- Locations
- 🇬🇧
Quotient Sciences, Nottingham, Nottinghamshire, United Kingdom
A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2023-05-10
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 18
- Registration Number
- NCT05852769
- Locations
- 🇺🇸
ICON plc, Millcreek, Utah, United States
A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 8
- Registration Number
- NCT05847439
- Locations
- 🇺🇸
Labcorp Clinical Research Unit - Madison, Madison, Wisconsin, United States
DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation
- Conditions
- Atrial FibrillationAtrial Flutter
- Interventions
- Diagnostic Test: 14-days continuous ECG monitoringDiagnostic Test: Risk prediction model
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 2112
- Registration Number
- NCT05838781
- Locations
- 🇸🇪
Karolinska Institutet Danderyd University Hospital, Stockholm, Outside US, Sweden
🇸🇪Halland Hospital Varberg, Varberg, Outside US, Sweden
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 1216
- Registration Number
- NCT05827016
- Locations
- 🇹🇷
Local Institution - 0068, Istanbul, Turkey
🇺🇸Rocky Mountain Cancer Centers, Aurora, Colorado, United States
🇺🇸Mayo Clinic Florida, Jacksonville, Florida, United States
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 25
- Registration Number
- NCT05813717
- Locations
- 🇺🇸
Local Institution - 0001, Cypress, California, United States
A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
- Conditions
- Relapsing-remitting Multiple Sclerosis (RRMS)
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 200
- Registration Number
- NCT05811416
- Locations
- 🇪🇸
Local Institution - 0001, Barcelona, Spain
A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants
- First Posted Date
- 2023-04-10
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 33
- Registration Number
- NCT05806359
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants
- First Posted Date
- 2023-04-10
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 24
- Registration Number
- NCT05805904
- Locations
- 🇨🇳
Local Institution - 0001, Shanghai, China
A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer
- Conditions
- Esophageal CarcinomaGastroesophageal Junction Carcinoma
- First Posted Date
- 2023-03-23
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 314
- Registration Number
- NCT05780736
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Pacific Central Coast Health Centers - San Luis Obispo Oncology and Hematology Health Center, San Luis Obispo, California, United States
🇺🇸Mission Cancer Center, Santa Maria, California, United States